Sabag Mark
- SEC CIK
- 0001721442
In the past year, 3 open-market sale filings worth $13.1M and no purchases.
Current role at each company
- TEVA Teva Pharmaceutical Industries LtdSee "Remarks"as of May 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $13.1M
- 3 filings
- Net
- −$13.1M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sabag Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 (view filing) | May 1 | 3 days | Sabag MarkSee "Remarks" | SSale | −144.2K | $34.99 | −$5.04M | −64.1%80.8K after | |
| Mar 19, 2026 (view filing) | Mar 17 | 2 days | Sabag MarkSee "Remarks" | SSale | −62.1K | $30.14 | −$1.87M | −21.6%224.9K after | |
| Dec 11, 2025 (view filing) | Dec 9 | 2 days | Sabag MarkSee "Remarks" | SSale | −216.9K | $28.73 | −$6.23M | −80.4%52.8K after | 2 lots |
| May 12, 2025 (view filing) | May 8 | 4 days | Sabag MarkSee "Remarks" | SSale | −337.9K | $18.04 | −$6.10M | −69.1%151.0K after | |
| Feb 14, 2025 (view filing) | Feb 12 | 2 days | Sabag MarkSee "Remarks" | SSale | −177.6K | $16.25 | −$2.89M | −46.4%205.0K after | |
| Mar 7, 2024 (view filing) | Mar 5 | 2 days | Sabag MarkEVP, International Markets | SSale | −100.0K | $13.52 | −$1.35M | −20.7%382.6K after |